These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28827488)

  • 1. Bilateral Ptosis due to Sympathetic Dysfunction as a Feature of Guillain-Barre Syndrome.
    Panosyan FB
    J Clin Neuromuscul Dis; 2017 Sep; 19(1):38-42. PubMed ID: 28827488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A; Borruat FX
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barré syndrome.
    Anandan C; Khuder SA; Koffman BM
    Muscle Nerve; 2017 Aug; 56(2):331-333. PubMed ID: 28039863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of parasympathetic functions in Guillain-Barré syndrome].
    Yamamoto T; Tamura N; Nakazato Y; Itokawa K; Maeda A; Abe T; Shimazu K
    Rinsho Shinkeigaku; 2002 Feb; 42(2):126-30. PubMed ID: 12424961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ; Yang HK; Hwang JM
    PLoS One; 2017; 12(6):e0178361. PubMed ID: 28575101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible cerebral vasoconstriction in Guillain-Barré syndrome.
    Wei DY; Kao J; Wu TY; Pereira JA; Anderson NE; Alan Barber P
    J Clin Neurosci; 2015 Jul; 22(7):1201-2. PubMed ID: 25778383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal cardiovascular autonomic function study in mild Guillain-Barré syndrome.
    Lyu RK; Tang LM; Hsu WC; Chen ST; Chang HS; Wu YR
    Eur Neurol; 2002; 47(2):79-84. PubMed ID: 11844895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective autonomic screening in Guillain-Barré syndrome.
    Yerdelen D; Erol T; Karatas M
    Neurol India; 2010; 58(3):398-402. PubMed ID: 20644267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome.
    Nakane S; Higuchi O; Hamada Y; Maeda Y; Mukaino A; Sakai W; Kusunoki S; Matsuo H
    J Neuroimmunol; 2016 Jun; 295-296():54-9. PubMed ID: 27235349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Horner's syndrome associated with Guillain-Barré syndrome].
    El Hajjaji M; Deflorenne C; Dachy B
    Rev Neurol (Paris); 2003 Sep; 159(8-9):799-800. PubMed ID: 13679726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Looks can be deceiving: three cases of neurological diseases mimicking Guillain-Barrè syndrome.
    Sciacca G; Nicoletti A; Fermo SL; Mostile G; Giliberto C; Zappia M
    Neurol Sci; 2016 Apr; 37(4):541-5. PubMed ID: 26707616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.
    Tan CY; Shahrizaila N; Yeoh KY; Goh KJ; Tan MP
    Clin Auton Res; 2019 Jun; 29(3):339-348. PubMed ID: 29654380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage.
    Kauh CY; Bursztyn LL
    J Neuroophthalmol; 2015 Sep; 35(3):287-8. PubMed ID: 25768246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apraclonidine in the treatment of ptosis.
    Wijemanne S; Vijayakumar D; Jankovic J
    J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
    Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis.
    Flachenecker P
    J Neurol; 2007 May; 254 Suppl 2():II96-101. PubMed ID: 17503142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is serum bilirubin associated with the severity of Guillain-Barré syndrome?
    Li X; Li W; Shi X; Mo L; Luo Y; Qin L; Yang Z; Mo W
    Int J Neurosci; 2018 Jul; 128(7):595-599. PubMed ID: 29130362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we assess severity of Guillain-Barré syndrome using absolute monocyte count?
    Li X; Li W; Luo Y; Qin L; Su Q; Mo W
    Int J Lab Hematol; 2018 Aug; 40(4):488-492. PubMed ID: 29718547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.